Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

BACKGROUND: Millions of patients are treated with therapeutic monoclonal antibodies (Tmabs) for miscellaneous diseases. We investigated sera from six patients who received immune globulin, from one patient with refractory anti-neutrophil-cytoplasmic antibody (ANCA)-associated granulomatosis with pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Latus, Joerg, Klein, Reinhild, Koetter, Ina, Schwab, Matthias, Fritz, Peter, Kimmel, Martin, Alscher, M. Dominik, Braun, Niko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823999/
https://www.ncbi.nlm.nih.gov/pubmed/24244376
http://dx.doi.org/10.1371/journal.pone.0078856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823999/
https://www.ncbi.nlm.nih.gov/pubmed/24244376
http://dx.doi.org/10.1371/journal.pone.0078856

Ejemplares similares